thoughts on fair market cap assuming trials replicate or improve on results already seen?
It’s obviously a bit of an art at this early stage, but since buying soon after IPO I’ve had $120m as a target that I think is not unreasonable considering peers and realistic chance of revenues flowing by 2026
keen to hear views of others
above not financial advice!
- Forums
- ASX - By Stock
- LTP
- Ann: Trading Halt
Ann: Trading Halt, page-14
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LTP (ASX) to my watchlist
|
|||||
Last
82.5¢ |
Change
0.045(5.77%) |
Mkt cap ! $58.08M |
Open | High | Low | Value | Volume |
79.5¢ | 82.5¢ | 79.5¢ | $38.80K | 48.31K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 10580 | 80.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
82.5¢ | 8803 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 10580 | 0.805 |
3 | 37501 | 0.800 |
1 | 2200 | 0.795 |
1 | 825 | 0.790 |
2 | 13550 | 0.785 |
Price($) | Vol. | No. |
---|---|---|
0.825 | 8803 | 2 |
0.830 | 1210 | 1 |
0.835 | 10000 | 1 |
0.840 | 2223 | 2 |
0.845 | 21348 | 1 |
Last trade - 10.24am 16/07/2024 (20 minute delay) ? |
Featured News
LTP (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online